Relmada Therapeutics Inc (RLMD)

Relmada Therapeutics Inc (RLMD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $347M; returns 1 day -0.6%, 1 week +5.5%, 1 year +48.0%.

Relmada Therapeutics Inc. (RLMD) is a clinical-stage biotechnology company dedicated to creating treatments for central nervous system (CNS) and oncology conditions. Their pipeline focuses on NDV-01, a treatment for non-muscle invasive bladder cancer (NMIBC), and sepranolone, a therapy for compulsivity disorders.

Groups RLMD belongs to

• Biotechnology
• Clinical Stage Biotech
• Pharmaceuticals
• CNS Disorders
• Oncology
• Rare Diseases
• Prader-Willi Syndrome
• Healthcare
• Life Sciences
• Neuroscience

RLMD financial model: income statement, cash flow and balance sheet